Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study from Confirmatory Study in Adult Atopic Dermatitis Patients
jRCT2080220143Phase 3
- Sponsor
- Novartis
- Start
- Oct 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pimecrolimus in atopic dermatitis (AD), sponsored by Novartis.
02
Drugs
pimecrolimus
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT2080220143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220143.